We are pleased to announce the publication of the October 2024 edition of the Market Prognosis Global 2024-2028 report – providing unparalleled insights and forecasts for 220 countries across 11 regions - allowing you to optimize future geographic strategic planning and decision making.
In this release, discover:
- The drivers and constraints of Global pharmaceutical sales, which will fuel growth at a CAGR of 7.4%, for sales to reach US$2275 billion by 2028.
- Why cost containment and a restrictive pricing environment will limit pharmaceutical growth in the Major Developed markets group, despite measures to increase access to innovative medicines for cancer, chronic diseases, orphan diseases and obesity.
- How access to innovative products, the rise of medical tourism, and expanded insurance coverage will shape the future of healthcare in South-East & East Asia in the face of pricing pressures and cost-containment measures.
- How acceleration of drug regulatory processes, expansion of healthcare services, and integration of digital health technologies, combined with investment-friendly policies will drive pharmaceutical market growth in the Middle East.
- How the demand of an ageing population and improvements in healthcare coverage will fuel market growth in the Latin American region, consisting of a diverse business operating environment: a robust regulatory framework in Brazil, inefficiencies in Mexico and a highly uncertain macroeconomic climate in Ecuador and Argentina.
Want to find out how Market Prognosis insights and forecasts can help you better understand challenges and opportunities in your markets? Please fill out the form and we will be in touch.
